M2-based influenza vaccines: recent advances and clinical potential
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
M2-based influenza vaccines: recent advances and clinical potential
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 16, Issue 2, Pages 123-136
Publisher
Informa UK Limited
Online
2016-09-22
DOI
10.1080/14760584.2017.1240041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical Synthesis of Monomeric, Dimeric and Tetrameric Forms of the Ectodomain of Influenza Matrix 2 Protein
- (2016) Weiguang Zeng et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus
- (2016) Yu-Na Lee et al. JOURNAL OF IMMUNOLOGY
- Protection against influenza A virus by vaccination with a recombinant fusion protein linking influenza M2e to human serum albumin (HSA)
- (2016) Xupeng Mu et al. JOURNAL OF VIROLOGICAL METHODS
- Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets
- (2016) Nedzad Music et al. VACCINE
- Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice
- (2016) C. Garrett Rappazzo et al. VACCINE
- Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice
- (2016) Jie Zhang et al. VACCINE
- Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
- (2015) Eugenia S. Mardanova et al. BMC BIOTECHNOLOGY
- Crystal Structure of the Conserved Amino Terminus of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus Gripped by an Antibody
- (2015) Ki Joon Cho et al. JOURNAL OF VIROLOGY
- Structure of the Extracellular Domain of Matrix Protein 2 of Influenza A Virus in Complex with a Protective Monoclonal Antibody
- (2015) Ki Joon Cho et al. JOURNAL OF VIROLOGY
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate
- (2015) Weiguang Zeng et al. VACCINE
- Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e
- (2015) Liudmila M. Tsybalova et al. VACCINE
- Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season
- (2015) Benjamin S. Chambers et al. Cell Reports
- A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells
- (2015) Venkateswara R. Simhadri et al. PLoS One
- Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages
- (2015) Lei Deng et al. PLoS One
- Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination
- (2014) Yu-Na Lee et al. IMMUNOLOGY
- Dynamics of Human Respiratory Virus-Specific CD8+ T Cell Responses in Blood and Airways during Episodes of Common Cold
- (2014) J. Heidema et al. JOURNAL OF IMMUNOLOGY
- Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza
- (2014) Eleanor L. Ramos et al. JOURNAL OF INFECTIOUS DISEASES
- Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model
- (2014) G. E. Price et al. JOURNAL OF VIROLOGY
- Stepwise Priming by Acidic pH and a High K+ Concentration Is Required for Efficient Uncoating of Influenza A Virus Cores after Penetration
- (2014) S. Stauffer et al. JOURNAL OF VIROLOGY
- Supplementation of Influenza Split Vaccines with Conserved M2 Ectodomains Overcomes Strain Specificity and Provides Long-term Cross Protection
- (2014) Min-Chul Kim et al. MOLECULAR THERAPY
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
- (2014) Annett Hessel et al. PLoS One
- Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: Extending the potential of broadly cross-protecting epitopes
- (2014) Nani Wibowo et al. VACCINE
- AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection
- (2014) Yu-Na Lee et al. VACCINE
- Vaccination with recombinant 4×M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens
- (2014) Mehran Dabaghian et al. VETERINARY MICROBIOLOGY
- Development of a heat-stable and orally delivered recombinant M2e-expressing B. subtilis spore-based influenza vaccine
- (2014) Guangyu Zhao et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and Protective Efficacy of Candidate Universal Influenza A Nanovaccines Produced in Plants by Tobacco Mosaic Virus-based Vectors
- (2013) Natalia Petukhova et al. CURRENT PHARMACEUTICAL DESIGN
- Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies
- (2013) S. Jegaskanda et al. JOURNAL OF IMMUNOLOGY
- Serum Antibody Response to Matrix Protein 2 Following Natural Infection With 2009 Pandemic Influenza A(H1N1) Virus in Humans
- (2013) Weimin Zhong et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza Virus
- (2013) V. Srivastava et al. JOURNAL OF VIROLOGY
- A Novel Subnucleocapsid Nanoplatform for Mucosal Vaccination against Influenza Virus That Targets the Ectodomain of Matrix Protein 2
- (2013) P.-L. Herve et al. JOURNAL OF VIROLOGY
- Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques
- (2013) S. Jegaskanda et al. JOURNAL OF VIROLOGY
- Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e
- (2013) Hana Kammoun et al. PLoS One
- A Novel M2e Based Flu Vaccine Formulation for Dogs
- (2013) Denis Leclerc et al. PLoS One
- Influenza virus hemagglutinin stalk-based antibodies and vaccines
- (2013) Florian Krammer et al. Current Opinion in Virology
- New World Bats Harbor Diverse Influenza A Viruses
- (2013) Suxiang Tong et al. PLoS Pathogens
- Universal vaccine against influenza virus: Linking TLR signaling to anti-viral protection
- (2012) Nicole Schmitz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Mouse Model for the Study of Contact-Dependent Transmission of Influenza A Virus and the Factors That Govern Transmissibility
- (2012) K. M. Edenborough et al. JOURNAL OF VIROLOGY
- Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
- (2012) Min-Chul Kim et al. MOLECULAR THERAPY
- Natural and long-lasting cellular immune responses against influenza in the M2e-immune host
- (2012) M Schotsaert et al. Mucosal Immunology
- Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge
- (2012) Hamidreza Hashemi et al. PLoS One
- Increased Immunogenicity and Protective Efficacy of Influenza M2e Fused to a Tetramerizing Protein
- (2012) Anne-Marie Carola Andersson et al. PLoS One
- A distinct lineage of influenza A virus from bats
- (2012) S. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice
- (2012) Paula Alvarez et al. VACCINE
- DNA-Vaccine Platform Development Against H1N1 Subtype of Swine Influenza A Viruses
- (2012) Huiling Wei et al. VIRAL IMMUNOLOGY
- A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles
- (2012) Elena A. Blokhina et al. VIROLOGY
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
- (2011) Jae-Min Song et al. PLoS One
- Vaccination with M2e-Based Multiple Antigenic Peptides: Characterization of the B Cell Response and Protection Efficacy in Inbred and Outbred Mice
- (2011) Amaya I. Wolf et al. PLoS One
- Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e
- (2011) Ki Seok Park et al. VACCINE
- Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
- (2011) Christine B. Turley et al. VACCINE
- A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody
- (2010) David Pejoski et al. IMMUNOLOGY AND CELL BIOLOGY
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- A Universal Influenza A Vaccine Based on Adenovirus Expressing Matrix-2 Ectodomain and Nucleoprotein Protects Mice From Lethal Challenge
- (2010) Dongming Zhou et al. MOLECULAR THERAPY
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses
- (2010) Andres G. Grandea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus
- (2010) J.-M. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proton and cation transport activity of the M2 proton channel from influenza A virus
- (2010) T. Leiding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
- (2009) Tong-Ming Fu et al. VACCINE
- The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine
- (2009) Fan Wu et al. VACCINE
- An update on swine-origin influenza virus A/H1N1: a review
- (2009) Sebastian U. Schnitzler et al. VIRUS GENES
- Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein
- (2008) R WANG et al. ANTIVIRAL RESEARCH
- An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2
- (2008) Marina De Filette et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasmid DNA–Based Vaccines Protect Mice and Ferrets against Lethal Challenge with A/Vietnam/1203/04 (H5N1) Influenza Virus
- (2008) Peggy A. Lalor et al. JOURNAL OF INFECTIOUS DISEASES
- Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform
- (2008) Jérôme Denis et al. VACCINE
- CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine
- (2008) Dubravka Grdic Eliasson et al. VACCINE
- Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus
- (2008) Tong-Ming Fu et al. VIROLOGY
- Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
- (2007) Juliana Bessa et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started